BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1403122)

  • 1. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
    Yoshida TK; Shimizu K; Koulousakis A; Sturm V
    J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
    Yoshida TK; Beuls E; Shimizu K; Koulousakis A; Sturm V
    Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
    Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal ACNU against experimental leptomeningeal tumors.
    Huang TY; Howng SL
    Kaohsiung J Med Sci; 1997 Oct; 13(10):626-30. PubMed ID: 9385779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal ACNU--a new therapeutic approach against malignant leptomeningeal tumors.
    Arita N; Ushio Y; Hayakawa T; Nagatani M; Huang TY; Izumoto S; Mogami H
    J Neurooncol; 1988 Nov; 6(3):221-6. PubMed ID: 3225641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
    Shimizu K; Ushio Y; Hayakawa T; Mogami H
    Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Overcoming of ACNU resistance in a subline of rat glioma in vitro and in vivo by reserpine].
    Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2141-6. PubMed ID: 3459396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
    Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
    No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
    Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
    No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intrathecal 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rats.
    Huang TY; Arita N; Ushio Y; Hayakawa T; Yamada K
    J Neurooncol; 1994; 19(3):245-50. PubMed ID: 7807175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation in vitro and in vivo of ACNU resistance in a subline of C6 glioma with reserpine.
    Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y
    J Neurosurg; 1987 Feb; 66(2):251-5. PubMed ID: 3468207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
    Yoshida T; Shimizu K; Hayakawa T; Mogami H; Sakamoto Y; Egawa T
    No Shinkei Geka; 1987 Mar; 15(3):261-7. PubMed ID: 3474542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of a rat meningeal gliomatosis model with neocarzinostatin].
    Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y; Egawa T
    No To Shinkei; 1987 Jul; 39(7):615-9. PubMed ID: 2960332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meningeal gliomatosis models as a chemosensitivity assay system].
    Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Nakata Y; Sakamoto Y
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):458-63. PubMed ID: 6584085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of blood-CSF barrier by tumor invasion into the meninges.
    Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
    J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
    Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
    Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.
    Mineura K; Watanabe K; Izumi I; Kowada M
    J Neurooncol; 1992 Nov; 14(3):201-5. PubMed ID: 1460484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model.
    Schabet M; Ohneseit P; Buchholz R; Santo-Höltje L; Schmidberger H
    J Neurooncol; 1992 Oct; 14(2):169-75. PubMed ID: 1432039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
    Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.